Registered entities
Innovation
19 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 2,869 times.
| Year | Filings |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 5 |
Social engagement
Social engagement: 14.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include Third Rock Ventures, Google Ventures, Foresite Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 65% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 5 | 29% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
1 May 2026 · Director-level roles across Analytical Chemistry, Biostatistics, Pharmapharmaceutical Development
9 Mar 2026 · Clinical Trial Manager · Cambridge
30 Aug 2025 · Director, Clinical Quality Assurance · Cambridge
30 Aug 2025 · Associate Director/Director, Clinical Operations · Cambridge
30 Aug 2025 · Director, Head of Medical Writing · Cambridge
Based on job postings tracked across public sources.
